PsyPost on MSN1d
Caffeine can disrupt your sleep — even when consumed 12 hours before bed
A recent study published in Sleep sheds light on the relationship between caffeine consumption and its impact on sleep.
Filter12d
Psilocybin Helped Doctors and Nurses Who Worked Through the Pandemic
A double-blind trial offered treatment to a group experiencing depression and burnout after traumatic times, with apparent ...
60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital
The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet ...
Corcept Therapeutics Diabetes Drug Korlym Meets Primary Endpoint in Study
Corcept Therapeutics drug Korlym, which treats hypercortisolism and difficult-to-control type 2 diabetes, met its primary endpoint in the treatment phase of CATALYST, a randomized, double-blind, ...
Targeted Oncology12d
Pelabresib Plus Ruxolitinib in JAK-Naive Myelofibrosis Maintains Benefit
The 48-week end points of the MANIFEST-2 study show improvements in spleen reduction, symptoms, bone marrow fibrosis, and ...
centerforbiosimilars13d
Pertuzumab Biosimilar Shows Promise in HER2-Positive Breast Cancer Treatment
The proposed pertuzumab biosimilar QL1209 demonstrated equivalent efficacy and safety to reference pertuzumab (Perjeta) in ...
Daily7d
Bovhyaluronidase azoximer may reduce exercise intolerance in patients with long-term pulmonary sequelae of COVID-19: Study
III-21," a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer ...
CervoMed's Dementia Candidate Fails In Mid-Stage Study, Stock Plummets
CervoMed reports RewinD-LB trial results for neflamapimod in dementia with Lewy bodies, highlighting missed endpoints and ...
Pharmabiz4d
Soligenix begins confirmatory phase 3 trial of HyBryte for treatment of cutaneous T-cell lymphoma
Soligenix begins confirmatory phase 3 trial of HyBryte for treatment of cutaneous T-cell lymphoma: Princeton, New Jersey Wednesday, December 18, 2024, 14:00 Hrs [IST] Soligenix, I ...